Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Tecovirimat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ACTG Announces Publication of STOMP Results in the NEJM
    ACTG Announces Publication of STOMP Results in the NEJM

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3245122/0/en/ACTG-Announces-Publication-of-STOMP-Results-in-the-New-England-Journal-of-Medicine.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    WHO Extends MPox Alert, NanoViricides' NV-387 in Focus
    WHO Extends MPox Alert, NanoViricides' NV-387 in Focus

    16 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/who-extended-global-emergency-status-of-mpox-epidemic-development-of-1049241

    ACCESSWIRE
    16 Jul 2025
    Share Share
    NanoViricides Nears Completion of MPox Clade I Trial Design
    NanoViricides Nears Completion of MPox Clade I Trial Design

    14 Jul 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/adaptive-clinical-protocol-design-for-phase-ii-mpox-clade-i-treatment-1048280

    ACCESSWIRE
    14 Jul 2025
    Share Share
    Tepoxx Approved in Japan for the Treatment of Orthopoxviruses
    Tepoxx Approved in Japan for the Treatment of Orthopoxviruses

    03 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/02/3003478/9738/en/TEPOXX-tecovirimat-Approved-in-Japan-for-the-Treatment-of-Orthopoxviruses.html

    GLOBENEWSWIRE
    03 Jan 2025
    Share Share
    Siga Reports Interim STOMP Study Results For Mpox Treatment
    Siga Reports Interim STOMP Study Results For Mpox Treatment

    10 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/10/2994943/9738/en/Interim-Results-from-STOMP-Study-of-SIGA-s-Tecovirimat-in-Treatment-of-Mpox-Announced.html

    GLOBENEWSWIRE
    10 Dec 2024
    Share Share
    SIGA Announces Agreement to Supply TPOXX® in Morocco
    SIGA Announces Agreement to Supply TPOXX® in Morocco

    08 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/10/08/2959574/9738/en/SIGA-Announces-Agreement-to-Supply-TPOXX-in-Morocco.html

    GLOBENEWSWIRE
    08 Oct 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.